Aprepitant and fosaprepitant as a prophylactic antiemetic for preventing postoperative nausea and vomiting after general anaesthesia: a systematic review and meta-analysis. [PDF]
Clinics (Sao Paulo)Grigio TR +5 more
europepmc +1 more source
Human Substance P Interactions with G Protein-Coupled Receptor NK1R Observed by NMR in Solution. [PDF]
J Am Chem SocGe H +5 more
europepmc +1 more source
Evaluating the potential to predict chemotherapy-induced nausea and vomiting in carboplatin-containing treatment based on symptoms induced by prior cisplatin-containing treatment. [PDF]
Sci RepSaito Y +6 more
europepmc +1 more source
Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer. [PDF]
Future OncolShin J, Kim JY, Ahn HK, Ahn JS, Park YH.
europepmc +1 more source
Personalized Prophylactic Antiemetic Regimens for Control of Chemotherapy-Induced Nausea and Vomiting by Pharmacogenetic Analysis of Three Receptor Genes: HTR3A, HTR3B, TACR1. [PDF]
JCO Precis OncolYeo W +11 more
europepmc +1 more source
Bidirectional substance P signaling between periodontal ligament fibroblasts and sensory neurons under mechanical stress. [PDF]
Front Mol NeurosciSymmank J +3 more
europepmc +1 more source
Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma. [PDF]
Cancers (Basel)Muñoz M, Rosso M.
europepmc +1 more source
Efficacy of intensive antiemetic therapy including olanzapine in multiple myeloma patients treated with high-dose melphalan with autologous stem cell transplantation. [PDF]
Support Care CancerKato J +12 more
europepmc +1 more source
Trigeminal nerve-driven neurogenic inflammation linking migraine to glioblastoma invasion: a literature review. [PDF]
Front ImmunolSong X +5 more
europepmc +1 more source